News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
711,582 Results
Type
Article (40403)
Company Profile (261)
Press Release (670907)
Multimedia
Podcasts (70)
Webinars (16)
Section
Business (204464)
Career Advice (2015)
Deals (35476)
Drug Delivery (99)
Drug Development (81230)
Employer Resources (173)
FDA (16309)
Job Trends (14914)
News (345890)
Policy (32682)
Tag
Academia (2557)
Accelerated approval (15)
Adcomms (24)
Allergies (112)
Alliances (49572)
ALS (131)
Alzheimer's disease (1548)
Antibody-drug conjugate (ADC) (189)
Approvals (16384)
Artificial intelligence (377)
Autoimmune disease (59)
Automation (25)
Bankruptcy (361)
Best Places to Work (11636)
BIOSECURE Act (20)
Biosimilars (144)
Biotechnology (175)
Bladder cancer (117)
Brain cancer (44)
Breast cancer (450)
Cancer (3538)
Cardiovascular disease (288)
Career advice (1691)
Career pathing (33)
CAR-T (215)
CDC (42)
Cell therapy (582)
Cervical cancer (30)
Clinical research (67788)
Collaboration (1247)
Company closure (4)
Compensation (900)
Complete response letters (42)
COVID-19 (2668)
CRISPR (70)
C-suite (523)
Cystic fibrosis (123)
Data (4138)
Decentralized trials (2)
Denatured (22)
Depression (90)
Diabetes (406)
Diagnostics (6521)
Digital health (32)
Diversity (10)
Diversity, equity & inclusion (45)
Drug discovery (174)
Drug pricing (152)
Drug shortages (28)
Duchenne muscular dystrophy (188)
Earnings (88635)
Editorial (45)
Employer branding (21)
Employer resources (150)
Events (114983)
Executive appointments (911)
FDA (18609)
Fibrodysplasia Ossificans Progressiva (3)
Friedreich's ataxia (5)
Frontotemporal dementia (13)
Funding (1130)
Gene editing (155)
Generative AI (28)
Gene therapy (465)
GLP-1 (851)
Government (4593)
Grass and pollen (5)
Guidances (334)
Healthcare (18854)
HIV (42)
Huntington's disease (34)
IgA nephropathy (50)
Immunology and inflammation (196)
Immuno-oncology (14)
Indications (51)
Infectious disease (2874)
Inflammatory bowel disease (167)
Inflation Reduction Act (12)
Influenza (83)
Intellectual property (176)
Interviews (314)
IPO (16607)
IRA (48)
Job creations (3639)
Job search strategy (1425)
Kidney cancer (13)
Labor market (67)
Layoffs (530)
Leadership (23)
Legal (7937)
Liver cancer (84)
Longevity (11)
Lung cancer (507)
Lymphoma (250)
Machine learning (27)
Management (59)
Manufacturing (559)
MASH (125)
Medical device (13585)
Medtech (13605)
Mergers & acquisitions (19714)
Metabolic disorders (1000)
Multiple sclerosis (130)
NASH (16)
Neurodegenerative disease (191)
Neuropsychiatric disorders (46)
Neuroscience (2467)
NextGen: Class of 2025 (6516)
Non-profit (4492)
Now hiring (56)
Obesity (474)
Opinion (235)
Ovarian cancer (120)
Pain (142)
Pancreatic cancer (159)
Parkinson's disease (221)
Partnered (27)
Patents (387)
Patient recruitment (286)
Peanut (52)
People (58145)
Pharmaceutical (63)
Pharmacy benefit managers (23)
Phase I (21099)
Phase II (29857)
Phase III (22204)
Pipeline (2574)
Policy (242)
Postmarket research (2564)
Preclinical (8987)
Press Release (64)
Prostate cancer (179)
Psychedelics (41)
Radiopharmaceuticals (256)
Rare diseases (568)
Real estate (5935)
Recruiting (68)
Regulatory (23338)
Reports (51)
Research institute (2347)
Resumes & cover letters (350)
Rett syndrome (14)
RNA editing (11)
RSV (61)
Schizophrenia (120)
Series A (185)
Series B (140)
Service/supplier (11)
Sickle cell disease (72)
Special edition (20)
Spinal muscular atrophy (149)
Sponsored (34)
Startups (3598)
State (2)
Stomach cancer (14)
Supply chain (91)
Tariffs (79)
The Weekly (46)
Vaccines (884)
Venture capital (62)
Weight loss (305)
Women's health (53)
Worklife (17)
Date
Today (89)
Last 7 days (507)
Last 30 days (2193)
Last 365 days (30574)
2025 (23479)
2024 (35218)
2023 (40076)
2022 (51175)
2021 (55710)
2020 (54083)
2019 (46538)
2018 (35018)
2017 (32108)
2016 (31480)
2015 (37552)
2014 (31318)
2013 (26345)
2012 (28570)
2011 (29263)
2010 (27328)
Location
Africa (725)
Alabama (71)
Alaska (7)
Arizona (265)
Arkansas (13)
Asia (38561)
Australia (6300)
California (8917)
Canada (2756)
China (806)
Colorado (376)
Connecticut (382)
Delaware (243)
Europe (83071)
Florida (1329)
Georgia (292)
Hawaii (2)
Idaho (60)
Illinois (697)
India (43)
Indiana (426)
Iowa (17)
Japan (298)
Kansas (116)
Kentucky (33)
Louisiana (16)
Maine (67)
Maryland (1176)
Massachusetts (6519)
Michigan (275)
Minnesota (520)
Mississippi (4)
Missouri (106)
Montana (29)
Nebraska (25)
Nevada (101)
New Hampshire (68)
New Jersey (2441)
New Mexico (28)
New York (2430)
North Carolina (1228)
North Dakota (8)
Northern California (4094)
Ohio (273)
Oklahoma (19)
Oregon (36)
Pennsylvania (1882)
Puerto Rico (18)
Rhode Island (43)
South America (1099)
South Carolina (45)
South Dakota (1)
Southern California (3435)
Tennessee (145)
Texas (1376)
United States (32407)
Utah (262)
Virginia (216)
Washington D.C. (76)
Washington State (746)
West Virginia (4)
Wisconsin (76)
Wyoming (1)
711,582 Results for "abveris inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Business
Enzolytics Inc. Announces Collaboration with Abveris to Discover Monoclonal Antibodies
Enzolytics, Inc. announces a collaboration with Abveris, a division of Twist Bioscience Corporation, to discover fully human monoclonal antibodies against multiple viruses.
September 16, 2022
·
3 min read
Press Releases
Apollomics, Inc. Company Operational Continuity Update
October 14, 2025
·
6 min read
Business
Abveris Named as One of the Best Places to Work
The Business Intelligence Group today announced that it has awarded Abveris a division of Twist Bioscience, a Best Places to Work 2022.
March 10, 2022
·
2 min read
Press Releases
Co-Diagnostics, Inc. to Attend 2025 Maxim Growth Summit
October 14, 2025
·
2 min read
Press Releases
FOXO TECHNOLOGIES INC. ANNOUNCES ACQUISITION AGREEMENT TO ACQUIRE VECTOR BIOSOURCE INC.
September 11, 2025
·
4 min read
Press Releases
Apogee Therapeutics, Inc. Announces Proposed Underwritten Public Offering
October 9, 2025
·
5 min read
Business
Abveris Announces Partnership with Foundery Innovations to Develop Therapeutics to Advance Immunotherapy
Abveris, Inc. (“Abveris”) announced today that it has entered into an antibody discovery partnership with Foundery Innovations, Inc. (“Foundery Innovations”) for the discovery of monoclonal antibodies to support the development of novel biotherapeutic drugs.
July 21, 2021
·
2 min read
Press Releases
KBI Biopharma, Inc. Announces Collaboration with Infinimmune Inc. to Support Antibody Manufacturing
September 9, 2025
·
3 min read
Business
Twist Bioscience Acquires Abveris to Complement Antibody Capabilities
Twist Bioscience snapped up in vivo antibody discovery company Abveris Inc. in a deal valued at up to $190 million. The acquisition is expected to bolster Twist’s biopharma antibody capabilities.
November 22, 2021
·
2 min read
·
Alex Keown
Press Releases
Revagenix, Inc. Announces Changes to Its Board of Directors
September 30, 2025
·
2 min read
1 of 71,159
Next
